Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mastec (MTZ) Asset Writedowns and Impairment (2019 - 2025)

Historic Asset Writedowns and Impairment for Mastec (MTZ) over the last 10 years, with Q1 2025 value amounting to -$706000.0.

  • Mastec's Asset Writedowns and Impairment fell 11357.69% to -$706000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$9.2 million, marking a year-over-year decrease of 3940.72%. This contributed to the annual value of $3.3 million for FY2019, which is 9303.64% down from last year.
  • As of Q1 2025, Mastec's Asset Writedowns and Impairment stood at -$706000.0, which was down 11357.69% from $5.2 million recorded in Q1 2024.
  • In the past 5 years, Mastec's Asset Writedowns and Impairment registered a high of $5.2 million during Q1 2024, and its lowest value of -$706000.0 during Q1 2025.
  • Over the past 3 years, Mastec's median Asset Writedowns and Impairment value was $500000.0 (recorded in 2023), while the average stood at $1.7 million.
  • In the last 5 years, Mastec's Asset Writedowns and Impairment skyrocketed by 94000.0% in 2024 and then tumbled by 11357.69% in 2025.
  • Quarter analysis of 3 years shows Mastec's Asset Writedowns and Impairment stood at $500000.0 in 2023, then skyrocketed by 940.0% to $5.2 million in 2024, then tumbled by 113.58% to -$706000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$706000.0 in Q1 2025, compared to $5.2 million in Q1 2024 and $500000.0 in Q1 2023.